Literature DB >> 22510477

Acute leukemia classification by ensemble particle swarm model selection.

Hugo Jair Escalante1, Manuel Montes-y-Gómez, Jesús A González, Pilar Gómez-Gil, Leopoldo Altamirano, Carlos A Reyes, Carolina Reta, Alejandro Rosales.   

Abstract

OBJECTIVE: Acute leukemia is a malignant disease that affects a large proportion of the world population. Different types and subtypes of acute leukemia require different treatments. In order to assign the correct treatment, a physician must identify the leukemia type or subtype. Advanced and precise methods are available for identifying leukemia types, but they are very expensive and not available in most hospitals in developing countries. Thus, alternative methods have been proposed. An option explored in this paper is based on the morphological properties of bone marrow images, where features are extracted from medical images and standard machine learning techniques are used to build leukemia type classifiers. METHODS AND MATERIALS: This paper studies the use of ensemble particle swarm model selection (EPSMS), which is an automated tool for the selection of classification models, in the context of acute leukemia classification. EPSMS is the application of particle swarm optimization to the exploration of the search space of ensembles that can be formed by heterogeneous classification models in a machine learning toolbox. EPSMS does not require prior domain knowledge and it is able to select highly accurate classification models without user intervention. Furthermore, specific models can be used for different classification tasks.
RESULTS: We report experimental results for acute leukemia classification with real data and show that EPSMS outperformed the best results obtained using manually designed classifiers with the same data. The highest performance using EPSMS was of 97.68% for two-type classification problems and of 94.21% for more than two types problems. To the best of our knowledge, these are the best results reported for this data set. Compared with previous studies, these improvements were consistent among different type/subtype classification tasks, different features extracted from images, and different feature extraction regions. The performance improvements were statistically significant. We improved previous results by an average of 6% and there are improvements of more than 20% with some settings. In addition to the performance improvements, we demonstrated that no manual effort was required during acute leukemia type/subtype classification.
CONCLUSIONS: Morphological classification of acute leukemia using EPSMS provides an alternative to expensive diagnostic methods in developing countries. EPSMS is a highly effective method for the automated construction of ensemble classifiers for acute leukemia classification, which requires no significant user intervention. EPSMS could also be used to address other medical classification tasks.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22510477     DOI: 10.1016/j.artmed.2012.03.005

Source DB:  PubMed          Journal:  Artif Intell Med        ISSN: 0933-3657            Impact factor:   5.326


  13 in total

1.  An Automatic and Robust Decision Support System for Accurate Acute Leukemia Diagnosis from Blood Microscopic Images.

Authors:  Zeinab Moshavash; Habibollah Danyali; Mohammad Sadegh Helfroush
Journal:  J Digit Imaging       Date:  2018-10       Impact factor: 4.056

Review 2.  Systematic Review of an Automated Multiclass Detection and Classification System for Acute Leukaemia in Terms of Evaluation and Benchmarking, Open Challenges, Issues and Methodological Aspects.

Authors:  M A Alsalem; A A Zaidan; B B Zaidan; M Hashim; O S Albahri; A S Albahri; Ali Hadi; K I Mohammed
Journal:  J Med Syst       Date:  2018-09-19       Impact factor: 4.460

3.  Automated Decision Support System for Detection of Leukemia from Peripheral Blood Smear Images.

Authors:  Roopa B Hegde; Keerthana Prasad; Harishchandra Hebbar; Brij Mohan Kumar Singh; I Sandhya
Journal:  J Digit Imaging       Date:  2020-04       Impact factor: 4.056

4.  Framework of Computer Aided Diagnosis Systems for Cancer Classification Based on Medical Images.

Authors:  Enas M F El Houby
Journal:  J Med Syst       Date:  2018-07-11       Impact factor: 4.460

5.  White blood cell differential count of maturation stages in bone marrow smear using dual-stage convolutional neural networks.

Authors:  Jin Woo Choi; Yunseo Ku; Byeong Wook Yoo; Jung-Ah Kim; Dong Soon Lee; Young Jun Chai; Hyoun-Joong Kong; Hee Chan Kim
Journal:  PLoS One       Date:  2017-12-11       Impact factor: 3.240

Review 6.  Intelligent Techniques Using Molecular Data Analysis in Leukaemia: An Opportunity for Personalized Medicine Support System.

Authors:  Haneen Banjar; David Adelson; Fred Brown; Naeem Chaudhri
Journal:  Biomed Res Int       Date:  2017-07-25       Impact factor: 3.411

7.  Training echo state networks for rotation-invariant bone marrow cell classification.

Authors:  Philipp Kainz; Harald Burgsteiner; Martin Asslaber; Helmut Ahammer
Journal:  Neural Comput Appl       Date:  2016-09-21       Impact factor: 5.606

8.  Artificial intelligence in health care: laying the Foundation for Responsible, sustainable, and inclusive innovation in low- and middle-income countries.

Authors:  Hassane Alami; Lysanne Rivard; Pascale Lehoux; Steven J Hoffman; Stéphanie Bernadette Mafalda Cadeddu; Mathilde Savoldelli; Mamane Abdoulaye Samri; Mohamed Ali Ag Ahmed; Richard Fleet; Jean-Paul Fortin
Journal:  Global Health       Date:  2020-06-24       Impact factor: 4.185

Review 9.  The Application of Medical Artificial Intelligence Technology in Rural Areas of Developing Countries.

Authors:  Jonathan Guo; Bin Li
Journal:  Health Equity       Date:  2018-08-01

10.  Assessment of dysplasia in bone marrow smear with convolutional neural network.

Authors:  Jinichi Mori; Shizuo Kaji; Hiroki Kawai; Satoshi Kida; Masaharu Tsubokura; Masahiko Fukatsu; Kayo Harada; Hideyoshi Noji; Takayuki Ikezoe; Tomoya Maeda; Akira Matsuda
Journal:  Sci Rep       Date:  2020-09-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.